The Ranitidine Tablets, cataloged under National Stock Number 6505-01-335-9163, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amneal Pharmaceuticals of New York, Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active.
| Item Name | Ranitidine Tablets |
| FSC / FSG | 6505 — Drugs and Biologicals (FSG 65) |
| Manufacturers | Par Pharmaceutical, Inc. Dba Par Pharmaceutical (CAGE 0VZ14); Amneal Pharmaceuticals of New York, Llc (CAGE 557X3); Avkare Llc (CAGE 4QGW8) |
| Parameter | Value |
|---|---|
| NSN | 6505-01-335-9163 |
| Primary Part Number | NDC65162-0253-11 |
| Item Name | Ranitidine Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amneal Pharmaceuticals of New York, Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 150.000 MILLIGRAMS RANITIDINE HYDROCHLORIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC49884-0544-10 | Par Pharmaceutical, Inc. Dba Par Pharmaceutical (USA) |
| NDC65162-0253-11 PRIMARY | Amneal Pharmaceuticals of New York, Llc (USA) |
| RANITADINE | Par Pharmaceutical, Inc. Dba Par Pharmaceutical (USA) |
| NDC42291-0724-10 PRIMARY | Avkare Llc (USA) |
NSN 6505-01-335-9163 is a Ranitidine Tablets, manufactured by Amneal Pharmaceuticals of New York, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-335-9163 has 4 manufacturer part numbers on file: NDC49884-0544-10 (Par Pharmaceutical, Inc. Dba Par Pharmaceutical), NDC65162-0253-11 (Amneal Pharmaceuticals of New York, Llc), RANITADINE (Par Pharmaceutical, Inc. Dba Par Pharmaceutical), NDC42291-0724-10 (Avkare Llc).
Key specifications for NDC65162-0253-11: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: RANITIDINE TABLETS USP 150MG 1000S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.